HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.

Abstract
Monoubiquitination and deubiquitination of FANCD2:FANCI heterodimer is central to DNA repair in a pathway that is defective in the cancer predisposition syndrome Fanconi anemia (FA). The "FA core complex" contains the RING-E3 ligase FANCL and seven other essential proteins that are mutated in various FA subtypes. Here, we purified recombinant FA core complex to reveal the function of these other proteins. The complex contains two spatially separate FANCL molecules that are dimerized by FANCB and FAAP100. FANCC and FANCE act as substrate receptors and restrict monoubiquitination to the FANCD2:FANCI heterodimer in only a DNA-bound form. FANCA and FANCG are dispensable for maximal in vitro ubiquitination. Finally, we show that the reversal of this reaction by the USP1:UAF1 deubiquitinase only occurs when DNA is disengaged. Our work reveals the mechanistic basis for temporal and spatial control of FANCD2:FANCI monoubiquitination that is critical for chemotherapy responses and prevention of Fanconi anemia.
AuthorsSylvie van Twest, Vincent J Murphy, Charlotte Hodson, Winnie Tan, Paolo Swuec, Julienne J O'Rourke, Jörg Heierhorst, Wayne Crismani, Andrew J Deans
JournalMolecular cell (Mol Cell) Vol. 65 Issue 2 Pg. 247-259 (Jan 19 2017) ISSN: 1097-4164 [Electronic] United States
PMID27986371 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier Inc. All rights reserved.
Chemical References
  • DNA-Binding Proteins
  • FAAP100 protein, human
  • FANCA protein, human
  • FANCB protein, human
  • FANCC protein, human
  • FANCD2 protein, human
  • FANCE protein, human
  • FANCG protein, human
  • FANCI protein, human
  • Fanconi Anemia Complementation Group A Protein
  • Fanconi Anemia Complementation Group C Protein
  • Fanconi Anemia Complementation Group D2 Protein
  • Fanconi Anemia Complementation Group E Protein
  • Fanconi Anemia Complementation Group G Protein
  • Fanconi Anemia Complementation Group Proteins
  • ID2 protein, human
  • Inhibitor of Differentiation Protein 2
  • Multiprotein Complexes
  • Nuclear Proteins
  • Recombinant Proteins
  • USP1 associated factor 1, human
  • DNA
  • FANCL protein, human
  • Fanconi Anemia Complementation Group L Protein
  • USP1 protein, human
  • Ubiquitin-Specific Proteases
Topics
  • Cell Line
  • DNA (genetics, metabolism)
  • DNA-Binding Proteins (metabolism)
  • Fanconi Anemia (genetics, metabolism)
  • Fanconi Anemia Complementation Group A Protein (metabolism)
  • Fanconi Anemia Complementation Group C Protein (metabolism)
  • Fanconi Anemia Complementation Group D2 Protein (genetics, metabolism)
  • Fanconi Anemia Complementation Group E Protein (metabolism)
  • Fanconi Anemia Complementation Group G Protein (metabolism)
  • Fanconi Anemia Complementation Group L Protein (metabolism)
  • Fanconi Anemia Complementation Group Proteins (genetics, metabolism)
  • Humans
  • Inhibitor of Differentiation Protein 2 (metabolism)
  • Multiprotein Complexes
  • Nuclear Proteins (metabolism)
  • Protein Binding
  • Protein Multimerization
  • Recombinant Proteins (metabolism)
  • Substrate Specificity
  • Time Factors
  • Transfection
  • Ubiquitin-Specific Proteases (metabolism)
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: